Rekombinanter BCL2A1 Antikörper
Kurzübersicht für Rekombinanter BCL2A1 Antikörper (ABIN5557421)
Target
Alle BCL2A1 Antikörper anzeigenAntikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- BCL2A1 Recombinant Antibody
-
Kreuzreaktivität
- Human, Maus
-
Homologie
- Rat
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- Recombinant human BCL2A1 protein, full length.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB(1:300-5000), IHC-P(1:200-400), IHC-F(1:100-500), IF(), ICC/IF(1:50-100)
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- 0.01M TBS ( pH 7.4), 1 % BSA, 0.02 % Proclin 300, and 50 % Glycerol
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- BCL2A1 (BCL2-Related Protein A1 (BCL2A1))
-
Andere Bezeichnung
- BCL2A1
-
Hintergrund
-
Synonyms: Bcl-2-related protein A1, BCL2A1, Bcl-2-like protein 5, Bcl2-L-5, Hemopoietic-specific early response protein, Protein BFL-1, Protein GRS
Background: Retards apoptosis induced by IL-3 deprivation. May function in the response of hemopoietic cells to external signals and in maintaining endothelial survival during infection (By similarity). Can inhibit apoptosis induced by serum starvation in the mammary epithelial cell line HC11.
-
Gen-ID
- 597
-
UniProt
- Q16548
Target
-